Ticker Scorecard - ALKS Basics Company: Alkermes plc Ordinary Shares IPO Date: August 1, 1991 Sector: Healthcare Industry: Biotech Market Cap: $5.74B Activated in VL: True Average Daily Range Avg Daily Range: $0.49 | 1.87% Avg Daily Range (30 D): $0.44 | 1.41% Avg Daily Range (90 D): $0.40 | 1.37% Institutional Daily Volume Avg Daily Volume: 1.06M Avg Daily Volume (30 D): 1.37M Avg Daily Volume (90 D): 1.3M Trade Size Avg Trade Size (Sh.): 122 Avg Trade Size (Sh.) (30 D): 69 Avg Trade Size (Sh.) (90 D): 69 Institutional Trades Total Inst.Trades: 12,970 Avg Inst. Trade: $2.45M Avg Inst. Trade (30 D): $3.58M Avg Inst. Trade (90 D): $3.49M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $4.98M Avg Closing Trade (30 D): $9.56M Avg Closing Trade (90 D): $9.33M Avg Closing Volume: 169.49K     News Jul 15, 2024 @ 9:00 PM 6 Analysts Assess Alkermes: What You Need To Know ... Source: Benzinga Insights, Benzinga Staff Writer Jun 24, 2024 @ 12:07 PM Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps... Source: Zacks Equity Research May 31, 2024 @ 3:31 PM Why Is Alkermes (ALKS) Down 2.7% Since Last Earnin... Source: Zacks Equity Research May 27, 2024 @ 10:20 AM Should You Invest in the Invesco S&P SmallCap Heal... Source: Zacks Equity Research May 23, 2024 @ 4:00 PM 6 Analysts Assess Alkermes: What You Need To Know Source: Benzinga Insights Financials   TTM Q4 2024 FY 2024 Basic EPS $2.22 $.9 $2.22 Diluted EPS $2.17 $.87 $2.17 Revenue $ 1.56B $ 429.99M $ 1.56B Gross Profit $ 1.31B $ 367.87M $ 1.31B Net Income / Loss $ 367.07M $ 146.5M $ 367.07M Operating Income / Loss $ 420.64M $ 162.69M $ 420.64M Cost of Revenue $ 245.33M $ 62.12M $ 245.33M Net Cash Flow $ -166.32M $ -105.15M $ -166.32M PE Ratio 16.28     Splits May 15, 2000:   1:2